$Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW)$

Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

Show other versions (1)

Bibliografske podrobnosti
Main Authors:	Ioannidis, G, Flahive, J, Pickard, L, Papaioannou, A, Chapurlat, R, Saag, K, Silverman, S, Anderson, F, Gehlbach, S, Hooven, F, Boonen, S, Compston, J, Cooper, C, Díez-Perez, A, Greenspan, S, LaCroix, A, Lindsay, R, Netelenbos, J, Pfeilschifter, J, Rossini, M, Roux, C, Sambrook, P, Siris, E, Watts, N, Adachi, J
Format:	Journal article
Izdano:	2012

Podobne knjige/članki

Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW).
od: Ioannidis, G, et al.
Izdano: (2013)

Obesity is not protective against fracture in postmenopausal women: GLOW.
od: Compston, J, et al.
Izdano: (2011)

Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).
od: Roux, C, et al.
Izdano: (2012)

EFFECT OF CO-MORBIDITIES ON FRACTURE RISK: FINDINGS FROM THE GLOW STUDY
od: Dennison, E, et al.
Izdano: (2011)

FRACTURE INCIDENCE IN OBESE POSTMENOPAUSAL WOMEN: THE GLOBAL STUDY OF OSTEOPOROSIS IN WOMEN (GLOW)
od: Compston, J, et al.
Izdano: (2012)

Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW).
od: Compston, J, et al.
Izdano: (2014)

Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
od: Dennison, E, et al.
Izdano: (2012)

Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)
od: Siris, E, et al.
Izdano: (2010)

Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW).
od: Siris, E, et al.
Izdano: (2011)

Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women.
od: Gehlbach, S, et al.
Izdano: (2012)

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.
od: Gregson, C, et al.
Izdano: (2014)

Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).
od: Compston, J, et al.
Izdano: (2014)

DISEASE-SPECIFIC PERCEPTION OF FRACTURE RISK AND INCIDENT FRACTURE RATES AMONG POSTMENOPAUSAL WOMEN: THE GLOW REGISTRY
od: Gregson, C, et al.
Izdano: (2013)

Predicting fractures in an international cohort using risk factor algorithms without BMD.
od: Sambrook, P, et al.
Izdano: (2011)

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study
od: Gregson, C, et al.
Izdano: (2014)

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.
od: Hooven, F, et al.
Izdano: (2009)

Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).
od: FitzGerald, G, et al.
Izdano: (2014)

When, where and how osteoporosis-associated fractures occur: an analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
od: Costa, A, et al.
Izdano: (2013)

Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women.
od: Pfeilschifter, J, et al.
Izdano: (2012)

Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women
od: Pfeilschifter, J, et al.
Izdano: (2011)

Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).
od: Díez-Pérez, A, et al.
Izdano: (2011)

Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).
od: Díez-Pérez, A, et al.
Izdano: (2014)

An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW).
od: Prieto-Alhambra, D, et al.
Izdano: (2013)

Characteristics associated with anti-osteoporosis medication use: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort
od: Guggina, P, et al.
Izdano: (2012)

Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.
od: Guggina, P, et al.
Izdano: (2012)

Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women.
od: Adachi, J, et al.
Izdano: (2010)

Frailty and fracture, disability, and falls: a multiple country study from the global longitudinal study of osteoporosis in women.
od: Tom, SE, et al.
Izdano: (2013)

FRACTURES IN OBESE POSTMENOPAUSAL WOMEN: PREVALENCE, SKELETAL LOCATION AND RISK FACTORS
od: Compston, J, et al.
Izdano: (2011)

Frailty and fracture, disability, and falls: A multiple country study from the global longitudinal study of osteoporosis in women
od: Tom, SE, et al.
Izdano: (2013)

RISK FACTOR CHARACTERISTICS OF WOMEN WITH INCIDENT FRACTURES: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
od: Hooven, F, et al.
Izdano: (2010)

Failure to Perceive Increased Risk of Fracture in Women >= 55 Years. The Global Longitudinal Registry of Osteoporosis in Women
od: Siris, E, et al.
Izdano: (2008)

Failure to perceive increased risk of fracture in women aged 55 years and older. The global longitudinal study of osteoporosis in women
od: Adami, S, et al.
Izdano: (2009)

Failure to perceive increased risk of fracture in women aged 55 years and older. The global longitudinal study of osteoporosis in women
od: Adami, S, et al.
Izdano: (2009)

REASONS FOR STOPPING ANTI-OSTEOPOROSIS MEDICATIONS AMONG POSTMENOPAUSAL WOMEN: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
od: Hooven, F, et al.
Izdano: (2010)

(PREMIER POSTER-AWARD CANDIDATE) CO-MORBIDITIES ASSOCIATED WITH FRACTURES IN POSTMENOPAUSAL WOMEN
od: Premaor, M, et al.
Izdano: (2010)

DISTRIBUTION OF RISK FACTORS FOR FRACTURE IN WOMEN WITH AND WITHOUT A FRACTURE HISTORY: A REGIONAL COMPARISON. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
od: Diez-Perez, A, et al.
Izdano: (2009)

Distribution of risk factors for fracture in women with and without a fracture history: A regional comparison. The global longitudinal registry of osteoporosis in women
od: Adachi, J, et al.
Izdano: (2008)

FAILURE TO PERCEIVE INCREASED RISK OF FRACTURE IN WOMEN 55 YEARS AND OLDER. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
od: Cooper, C, et al.
Izdano: (2009)

RISK FACTORS FOR FRAGILITY FRACTURE IN A MULTIRACIAL COHORT OF US WOMEN. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
od: Silverman, S, et al.
Izdano: (2009)

Patterns of anti-osteoporosis medication use among women at high risk of fracture: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
od: Stephen Gehlbach, et al.
Izdano: (2013-01-01)